Cargando…
Novel LIMK2 Inhibitor Blocks Panc-1 Tumor Growth in a mouse xenograft model
LIM kinases (LIMKs) are important cell cytoskeleton regulators that play a prominent role in cancer manifestation and neuronal diseases. The LIMK family consists of two homologues, LIMK1 and LIMK2, which differ from one another in expression profile, intercellular localization, and function. The mai...
Autores principales: | Rak, Roni, Haklai, Roni, Elad-Tzfadia, Galit, Wolfson, Haim J., Carmeli, Shmuel, Kloog, Yoel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295757/ https://www.ncbi.nlm.nih.gov/pubmed/25593987 |
Ejemplares similares
-
Computer-Based Identification of a Novel LIMK1/2 Inhibitor that Synergizes with Salirasib to Destabilize the Actin Cytoskeleton
por: Mashiach-Farkash, Efrat, et al.
Publicado: (2012) -
Chloroquine synergizes with FTS to enhance cell growth inhibition and cell death
por: Schmukler, Eran, et al.
Publicado: (2013) -
Growth of poorly differentiated endometrial carcinoma is inhibited by combined action of medroxyprogesterone acetate and the Ras inhibitor Salirasib
por: Faigenbaum, Raya, et al.
Publicado: (2013) -
H-Ras Nanocluster Stability Regulates the Magnitude of MAPK Signal Output
por: Rotblat, Barak, et al.
Publicado: (2010) -
Targeting LIM kinase in cancer and neurofibromatosis
por: Rak, Roni, et al.
Publicado: (2014)